Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
July 16, 2024 07:30 ET
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, July 16, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the “Company”) today announced the approval of a...
Cytokinetics Announces Seven Upcoming Presentations at the European Society of Cardiology Congress 2024
July 16, 2024 07:30 ET
|
Cytokinetics, Incorporated
Late Breaking Clinical Trial Presentations to Feature Additional Results from SEQUOIA-HCM Related to Patient-Reported Health Status, Cardiac Structure and Function and Biomarkers Analyses of Safety...
Amesite Launches PREACTO™ App in Beta to Power Safety and Security at Home, Work, School and in Public Venues
July 16, 2024 07:30 ET
|
Amesite Inc.
DETROIT, July 16, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence (AI) software company offering a cloud-based learning platform for business and education...
Streamline Health® Expands RevID™ Agreement With 400-Bed Children’s Health System
July 16, 2024 07:30 ET
|
Streamline Health Solutions, Inc.
ATLANTA, July 16, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance,...
Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference
July 16, 2024 07:30 ET
|
Evaxion Biotech
Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing a state-of-the-art...
MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program
July 16, 2024 07:30 ET
|
MediWound Ltd.
Funds to be used for clinical development of EscharEx® to treat diabetic foot ulcers (DFUs) Award advances MediWound’s DFU program and its future revenues four years ahead of original schedule ...
Repligen to Report Second Quarter 2024 Financial Results
July 16, 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2024 financial results on Tuesday, July 30, 2024....
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024 07:19 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on July 1,...
Atlantica Publishes Scheme Circular and Announces the Shareholder Meetings to Vote on its Acquisition by ECP and Co-Investors Will Be Held on August 8, 2024
July 16, 2024 07:16 ET
|
Atlantica Sustainable Infrastructure plc
Atlantica Publishes Scheme Circular and Announces the Shareholder Meetings to Vote on its Acquisition by ECP and Co-Investors Will Be Held on August 8, 2024 July 16, 2024 – Atlantica Sustainable...
Gilat Awarded Over $5M by a National Defense Organization for the Upgrade of Transportable SATCOM Network Hubs
July 16, 2024 07:03 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced...